Cprx stock earnings

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) reported earnings of 7 cents per share in the fourth quarter of 2019, missing the Zacks Consensus Estimate of 9� Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings,� CPRX. Delayed Nasdaq - 04/03 04:00:00 pm. 3.53USD. -2.49%. Upcoming events on CATALYST 08/11/20, Interim 2020 Earnings Release (Projected) 03/17/20 | 08:30am, FY 2019 Earnings Call Quarterly / Semiannualy publications�

Growth Rate, +150.0% *Last Qtr. Average EPS % Beat Rate, +132.6%, Revenue Growth Rate, N/A. Average % Move 1-Wk after EPS, +8.7%, Normal Earnings� CPRX: Catalyst Pharmaceuticals, Inc. Detailed Estimate. Get the latest View All Zacks #1 Ranked Stocks. Trades from $1 See Earnings Report Transcript� 9 Mar 2020 The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock� 17 Mar 2020 CPRX earnings call for the period ending December 31, 2019. We have also built significant safety stock into our supply chain to manage�

Find the latest and the upcoming Catalyst Pharma earnings report Apr 3, 2020 as well as EPS Forecast and CPRX top analyst price target The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique datasets.

17 Mar 2020 CPRX earnings call for the period ending December 31, 2019. We have also built significant safety stock into our supply chain to manage� Stock Price Forecast The current consensus among 6 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Earnings and Sales Forecasts� In depth view into CPRX (Catalyst Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Catalyst Pharmaceuticals Reports Q4 GAAP Earnings Per Share $0.07 BRIEF- Catalyst Pharma Announces Proposed Public Offering Of Common Stock. Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) reported earnings of 7 cents per share in the fourth quarter of 2019, missing the Zacks Consensus Estimate of 9� Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings,�

View Catalyst Pharmaceuticals' (NASDAQ:CPRX) earnings history, next earnings date and MarketBeat - Stock Market News and Research Tools logo.

Catalyst Pharmaceuticals, Inc. (CPRX) latest earnings report: revenue, EPS, surprise, history, news and analysis. Growth Rate, +150.0% *Last Qtr. Average EPS % Beat Rate, +132.6%, Revenue Growth Rate, N/A. Average % Move 1-Wk after EPS, +8.7%, Normal Earnings� CPRX: Catalyst Pharmaceuticals, Inc. Detailed Estimate. Get the latest View All Zacks #1 Ranked Stocks. Trades from $1 See Earnings Report Transcript�

Growth Rate, +150.0% *Last Qtr. Average EPS % Beat Rate, +132.6%, Revenue Growth Rate, N/A. Average % Move 1-Wk after EPS, +8.7%, Normal Earnings�

Stock Price Forecast The current consensus among 6 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Earnings and Sales Forecasts� In depth view into CPRX (Catalyst Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.

In depth view into CPRX (Catalyst Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.

Stock Price Forecast The current consensus among 6 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Earnings and Sales Forecasts� In depth view into CPRX (Catalyst Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Catalyst Pharmaceuticals Reports Q4 GAAP Earnings Per Share $0.07 BRIEF- Catalyst Pharma Announces Proposed Public Offering Of Common Stock.

In depth view into CPRX (Catalyst Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Catalyst Pharmaceuticals Reports Q4 GAAP Earnings Per Share $0.07 BRIEF- Catalyst Pharma Announces Proposed Public Offering Of Common Stock. Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) reported earnings of 7 cents per share in the fourth quarter of 2019, missing the Zacks Consensus Estimate of 9� Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings,�